Our team is what makes us who we are. And who we are is born from the constantly evolving nature of the team.
We recently reached (and have now surpassed!) the 100-employee mark – a sign of both the success and the potential of Generation Bio.
Together, we work toward our shared goal of delivering brighter futures for people living with genetic disease. Together, we forge through setbacks. Together, we celebrate successes. Together, we advance our mission.
To celebrate the milestone of “100 Strong,” we have created a video capturing some of the most memorable moments at Generation Bio in recent years. Enjoy!
Safe Harbor Statement: Any statements in this Blog about our future expectations, plans and prospects, including statements relating to about our strategic plans or objectives, our technology platforms, our research and clinical development plans, and other statements containing the words “believes,” “anticipates,” “plans,” “expects,” and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: uncertainties inherent in the identification and development of product candidates, including the conduct of research activities; the initiation and completion of preclinical studies and clinical trials and clinical development of any product candidates; whether results from preclinical studies will be predictive of the results of later preclinical studies and clinical trials; expectations for regulatory approvals to conduct trials or to market products; challenges in the manufacture of genetic medicine products; our ability to obtain sufficient cash resources to fund our foreseeable and unforeseeable operating expenses and capital expenditure requirements; and the impact of the COVID-19 pandemic on our business and operations; as well as the other risks and uncertainties set forth in the “Risk Factors” section of our annual report on Form 10-K, as updated by our most recent quarterly report on Form 10-Q, which are on file with the Securities and Exchange Commission, and in any subsequent filings we may make with the Securities and Exchange Commission. In addition, the forward-looking statements included in this Blog represent our views as of the date hereof. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we specifically disclaim any obligation to do so. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date on which they were made.